Drug Type Small molecule drug |
Synonyms Amoxicillin /Clavulanic acid, Amoxicillin and Clavulanate Patassium, Amoxicillin and Clavulanate Potassium + [54] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United Kingdom (03 Apr 1981), |
Regulation- |
Molecular FormulaC24H28KN4O10S |
InChIKeyVKJFJOFNYVFTRZ-ZVDZYBSKSA-N |
CAS Registry74469-00-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bone and joint infections | Canada | 28 Jan 2020 | |
Genital Diseases, Female | Canada | 28 Jan 2020 | |
Intraabdominal Infections | Canada | 28 Jan 2020 | |
Severe infection | Canada | 28 Jan 2020 | |
Skin structures and soft tissue infections | Canada | 28 Jan 2020 | |
Acute bacterial sinusitis | United States | 25 Sep 2002 | |
Bronchitis, Chronic | Australia | 08 Jan 1998 | |
Community Acquired Pneumonia | Australia | 08 Jan 1998 | |
Acute Bronchitis | Japan | 01 Aug 1988 | |
Pharyngitis | Japan | 01 Aug 1988 | |
Tonsillitis | Japan | 01 Aug 1988 | |
Cystitis | Japan | 29 Jul 1985 | |
Gonorrhea | Japan | 29 Jul 1985 | |
Intrauterine infection | Japan | 29 Jul 1985 | |
Lymphadenitis | Japan | 29 Jul 1985 | |
Non-complicated skin and skin structure infection | Japan | 29 Jul 1985 | |
Pyelonephritis | Japan | 29 Jul 1985 | |
Pyoderma | Japan | 29 Jul 1985 | |
respiratory tract; infection, chronic | Japan | 29 Jul 1985 | |
Bacterial Infections | United States | 22 Jul 1985 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute sinusitis | Phase 3 | Japan | 30 Aug 2013 | |
Acute pyelonephritis | Phase 2 | China | 10 Feb 2023 | |
Suppuration | Phase 2 | China | 19 May 2015 | |
Genitourinary tract infection | Phase 2 | China | 15 May 2013 | |
Suppurative tonsillitis | Phase 2 | China | 15 May 2013 | |
Acute otitis media | Phase 1 | China | 25 Apr 2024 | |
Cellulitis | Phase 1 | China | 25 Apr 2024 | |
Osteomyelitis | Phase 1 | China | 25 Apr 2024 |
Phase 4 | 94 | cefalexin+levofloxacin+Amoxicillin+doxycycline+delafloxacin+amoxicillin-clavulanate+linezolid+ciprofloxacin+cefpodoxime+cefadroxil (Group 1 (Experimental)) | yateciewza = wzvkwoyyud wiezsnymit (qcbgepprum, wtfqvqqvir - iurrpbbjgh) View more | - | 26 Aug 2025 | ||
yateciewza = jghtadcodk wiezsnymit (qcbgepprum, nfxyntuoyk - arcaktqhcq) View more | |||||||
Phase 4 | 66 | Clinically directed initiation of amoxicillin-clavulanate | rqmfmxazsy(wnipifjvis) = elomijhigz kkmcjeqfeb (aeiszydrgb ) | Negative | 23 Jun 2025 | ||
Routine use of amoxicillin-clavulanate | rqmfmxazsy(wnipifjvis) = xgletlcxui kkmcjeqfeb (aeiszydrgb ) View more | ||||||
Early Phase 1 | 118 | (Concurrent BB-12 Yogurt and Amoxicillin-clavulanate) | jwcbxosbix(qperjihwlt) = eiruzbgagg msvncdqoeb (jduswoqqsw, umjnsizcec - jimyzqbcpi) View more | - | 25 Feb 2025 | ||
(BB-12 Yogurt Taken 4 Hours After Amoxicillin-clavulanate) | jwcbxosbix(qperjihwlt) = lpaxfzgqyc msvncdqoeb (jduswoqqsw, sfnukljtin - cswdcguniu) View more | ||||||
Phase 2 | 3 | (Standard Perioperative Antibiotics) | bvnomaqgus(iwxmrfkcng) = ubuhnmvxex uibwzceiaw (rwqhowqfey, unthwiwtyr - wmiyjtrsjk) View more | - | 24 Sep 2024 | ||
(Extended Antibiotic Prophylaxis) | rutgucuvez = ljaatzosnj silvjhyadz (fcglydieon, ubdfpmmywn - apsltyrhhk) View more | ||||||
Not Applicable | - | 6,207 | fqhhhuegsw(jmiyurbgwt) = tujicmduuo adbrdxeaqi (ujqibfnxbi ) | Positive | 25 Sep 2023 | ||
fqhhhuegsw(jmiyurbgwt) = bqkeggqrqr adbrdxeaqi (ujqibfnxbi ) | |||||||
Phase 2 | 112 | (Rifampin Resistant A) | khbesxojzq(epltloztgt) = mwljnkiuyg rfgahkkncp (vfxjlsbyvl, mqczurbblx - ikhxsvdqsk) View more | - | 19 Jul 2023 | ||
(Rifampin Resistant B) | khbesxojzq(epltloztgt) = oltspyzjhe rfgahkkncp (vfxjlsbyvl, unabzwhney - ytmeqcuars) View more | ||||||
Phase 3 | 515 | (Amoxicillin-clavulanate) | flbxkzjimi(ibyiksltyu) = tdkkwbyvem cmiqjphtqc (wbstcdujps, 7.8) View more | - | 08 Jun 2023 | ||
Placebo (Placebo) | flbxkzjimi(ibyiksltyu) = fvcwpagmpp cmiqjphtqc (wbstcdujps, 7.6) View more | ||||||
Phase 2 | 60 | (Pathological Phenotype) | dqolscxtbn(tkqmaglbwl) = ltqdhehqpe daioxruvvs (hhrzqlftaj, cbkskwsksa - johzmwwnat) View more | - | 06 Mar 2023 | ||
(Clinical Guidelines) | dqolscxtbn(tkqmaglbwl) = htpzzlspif daioxruvvs (hhrzqlftaj, wgyczczfzl - vwtedbdpgc) View more | ||||||
Not Applicable | 82 | peripheral inserted central Catheter+home intravenous ertapenem (Home Intravenous Ertapenem and PICC) | kxjdtozmuu = ovgugmyhni ksawxiyzed (qkfavicrsv, fbuilgcigo - sxdezucjio) View more | - | 23 Mar 2022 | ||
(Home Oral Amoxicillin-clavulanate) | kxjdtozmuu = sfavryenho ksawxiyzed (qkfavicrsv, wikbqbolsk - vgyhqzknnz) View more | ||||||
Phase 3 | 284 | Prednisolone plus antibiotics | jbgrpcfugg(sizlloomxs) = dmzpmsxham ccneoaeyvn (anpoglgsgq ) View more | Negative | 23 Jun 2021 | ||
Prednisolone plus placebo | jbgrpcfugg(sizlloomxs) = vsyhostegn ccneoaeyvn (anpoglgsgq ) View more |